Cyclic amplification and selection of targets for multicomponent complexes: myogenin interacts with factors recognizing binding sites for basic helix-loop-helix, nuclear factor 1, myocyte-specific enhancer-binding factor 2, and COMP1 factor
about
PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's diseaseThe LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteinsDNA binding and transcriptional activation by the Ski oncoprotein mediated by interaction with NFICombinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factorsJUMONJI, a critical factor for cardiac development, functions as a transcriptional repressorMEF2 protein expression, DNA binding specificity and complex composition, and transcriptional activity in muscle and non-muscle cellsTransient expression of a winged-helix protein, MNF-beta, during myogenesisExtracellular deposition of matrilin-2 controls the timing of the myogenic program during muscle regeneration.Lineage-based primary muscle fiber type diversification independent of MEF2 and NFAT in chick embryosSynergistic interactions between heterologous upstream activation elements and specific TATA sequences in a muscle-specific promoter.A combination of MEF3 and NFI proteins activates transcription in a subset of fast-twitch muscles.HEN1 encodes a 20-kilodalton phosphoprotein that binds an extended E-box motif as a homodimerA Mef2 gene that generates a muscle-specific isoform via alternative mRNA splicing.Novel muscle-specific enhancer sequences upstream of the cardiac actin geneMultiplex selection technique (MuST): an approach to clone transcription factor binding sites.MyoD and myogenin act on the chicken myosin light-chain 1 gene as distinct transcriptional factors.Genetic variation in the porcine myogenin gene locus.Differential expression of the myocyte enhancer factor 2 family of transcription factors in development: the cardiac factor BBF-1 is an early marker for cardiogenesis.A novel site, Mt, in the human desmin enhancer is necessary for maximal expression in skeletal muscle.A muscle-specific enhancer within intron 1 of the human dystrophin gene is functionally dependent on single MEF-1/E box and MEF-2/AT-rich sequence motifs.Nfix Regulates Temporal Progression of Muscle Regeneration through Modulation of Myostatin Expression.Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia.Myogenin and MEF2 function synergistically to activate the MRF4 promoter during myogenesis.Differences between MyoD DNA binding and activation site requirements revealed by functional random sequence selection.Novel CAR-mediated mechanism for synergistic activation of two distinct elements within the human cytochrome P450 2B6 gene in HepG2 cells.An E box in the desmin promoter cooperates with the E box and MEF-2 sites of a distal enhancer to direct muscle-specific transcription.TREMOR--a tool for retrieving transcriptional modules by incorporating motif covariance.Basic helix-loop-helix factors recruit nuclear factor I to enhance expression of the NaV 1.4 Na+ channel gene.
P2860
Q24294809-1F07F474-0C57-47DA-943B-B132F5F54D0AQ24532225-43B00AFF-B747-43D2-B425-321B2BB25DC7Q24545461-10077CA9-41AF-40C9-B700-B62F9D6E4F0FQ24594377-3A10D71A-5BA5-464A-BE92-ECDC5A427D8CQ28190873-9C814EDD-96FC-451B-9F73-11ACF3DB3089Q28289460-27A7B025-ED82-4F5E-9781-179EF8C36E43Q28587918-D27CA41B-95A3-4051-9AA3-C6247D7E5902Q33980534-3FDDD590-77D3-441C-96C3-BC68FD34618FQ36072646-54F13C7C-93A3-485A-A4A6-19265A9197C9Q36550233-DA805038-9C36-4F56-BFDA-6074FB2595CAQ36565168-A730C620-9536-4A07-86D2-E81FB6AF16B6Q36646393-64871014-496B-4A53-B712-616D81FC1702Q36647589-3299096E-6E88-405F-989F-E96E26B28B7AQ36653449-B35D1E0B-FA91-4DCB-9494-00F57DD40B45Q36792875-ACDA0A58-78EC-42C4-9D7E-17DAB07886C4Q36826381-10789690-69DA-4398-899D-3082F4BB5004Q36875405-067F67FE-62D2-4B03-A57A-D7D883C6F000Q38305761-446AFA15-F352-4491-ACC5-0B4B44F7B167Q38338640-587C67CF-1B0E-43FC-B922-0C5F692F08ADQ38346817-68F11763-E232-4D60-A54E-1A34B102663DQ38790394-31902718-5F63-49D7-8B3A-3A04524942BAQ39873602-C4511815-B576-4E85-9519-133B5BDC1FD6Q40016249-96A315F3-A993-42EC-BE4B-02CC81C98F68Q40019388-C31741B3-62BF-47D7-8B95-1C5D3C0615D9Q40488292-A4D9B722-B89C-49BB-8F19-13C02B9C6091Q40792743-3CF8E390-7FC3-4FFB-9DD7-3E08D870CE88Q41835652-7D1AF8D6-2228-488F-BC70-1E796F54B4F5Q42920963-D369091A-749F-4E70-8B36-47D9E9556495
P2860
Cyclic amplification and selection of targets for multicomponent complexes: myogenin interacts with factors recognizing binding sites for basic helix-loop-helix, nuclear factor 1, myocyte-specific enhancer-binding factor 2, and COMP1 factor
description
1992 nî lūn-bûn
@nan
1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Cyclic amplification and selec ...... ing factor 2, and COMP1 factor
@ast
Cyclic amplification and selec ...... ing factor 2, and COMP1 factor
@en
Cyclic amplification and selec ...... ing factor 2, and COMP1 factor
@nl
type
label
Cyclic amplification and selec ...... ing factor 2, and COMP1 factor
@ast
Cyclic amplification and selec ...... ing factor 2, and COMP1 factor
@en
Cyclic amplification and selec ...... ing factor 2, and COMP1 factor
@nl
prefLabel
Cyclic amplification and selec ...... ing factor 2, and COMP1 factor
@ast
Cyclic amplification and selec ...... ing factor 2, and COMP1 factor
@en
Cyclic amplification and selec ...... ing factor 2, and COMP1 factor
@nl
P2860
P356
P1476
Cyclic amplification and selec ...... ing factor 2, and COMP1 factor
@en
P2093
P2860
P304
P356
10.1073/PNAS.89.20.9484
P407
P577
1992-10-15T00:00:00Z